Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionMitchell Mcleod Pugh & Williams Inc
Latest Disclosed Ownership1,952 shares
Latest Disclosed Value $ 686,845
Mitchell Mcleod Pugh & Williams Inc reports 1.04% increase in ownership of AMGN / Amgen Inc.

On April 24, 2026 - Mitchell Mcleod Pugh & Williams Inc filed a 13F-HR form disclosing ownership of 1,952 shares of Amgen Inc. (CH:AMGN) valued at $686,845 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,932 shares of Amgen Inc.. This represents a change in shares of 1.04% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F AMGEN COM 031162100 1,952 20 1.04 687 -7.55 0.0767
2026-02-11 2025-12-31 13F AMGEN COM 031162100 1,932 743
2025-10-30 2025-09-30 13F AMGEN COM 031162100 1,933 -537 -21.74 565 -18.14 0.0908
2025-07-28 2025-06-30 13F AMGEN COM 031162100 2,470 109 4.62 690 -6.26 0.1285
2025-05-01 2025-03-31 13F AMGEN COM 031162100 2,361 78 3.42 736 23.53 0.1522
2025-01-16 2024-12-31 13F AMGEN COM 031162100 2,283 -472 -17.13 595 -32.92 0.1249
2024-11-04 2024-09-30 13F AMGEN COM 031162100 2,755 0 0.00 888 3.14 0.1853
2024-07-31 2024-06-30 13F AMGEN COM 031162100 2,755 0 0.00 861 9.83 0.1965
2024-05-01 2024-03-31 13F AMGEN COM 031162100 2,755 331 13.66 783 12.18 0.1885
2024-02-05 2023-12-31 13F AMGEN COM 031162100 2,424 176 7.83 698 15.56 0.1848
2023-10-20 2023-09-30 13F AMGEN COM 031162100 2,248 147 7.00 604 29.61 0.1780
2023-08-08 2023-06-30 13F AMGEN COM 031162100 2,101 -13 -0.61 467 -8.81 0.1349
2023-05-10 2023-03-31 13F AMGEN COM 031162100 2,114 -13 -0.61 511 -8.42 0.1589
2023-02-03 2022-12-31 13F AMGEN COM 031162100 2,127 -4 -0.19 559 16.25 0.1890
2022-11-07 2022-09-30 13F AMGEN COM 031162100 2,131 30 1.43 480 -6.07 0.1846
2022-11-18 2022-06-30 13F/A-1 AMGEN COM 031162100 2,101 13 0.62 511 1.19 0.1983
2022-07-19 2022-06-30 13F AMGEN COM 031162100 2,101 13 511 0.1992
2022-04-26 2022-03-31 13F AMGEN COM 031162100 2,088 -14 -0.67 505 6.77 0.1694
2022-02-02 2021-12-31 13F AMGEN COM 031162100 2,102 -2,136 -50.40 473 -47.50 0.1562
2021-11-08 2021-09-30 13F AMGEN COM 031162100 4,238 0 0.00 901 -12.78 0.3343
2021-11-08 2021-06-30 13F/A-1 AMGEN COM 031162100 4,238 0 0.00 1,033 -2.09 0.3973
2021-08-03 2021-06-30 13F AMGEN COM 031162100 4,211 -27 1,027 0.3018
2021-05-12 2021-03-31 13F AMGEN COM 031162100 4,238 -6 -0.14 1,055 8.09 0.4411
2021-02-08 2020-12-31 13F AMGEN COM 031162100 4,244 0 0.00 976 -9.55 0.4483
2020-10-27 2020-09-30 13F AMGEN COM 031162100 4,244 0 0.00 1,079 7.79 0.5519
2020-07-17 2020-06-30 13F AMGEN COM 031162100 4,244 -712 -14.37 1,001 -0.40 0.5694
2020-04-08 2020-03-31 13F AMGEN COM 031162100 4,956 0 0.00 1,005 -15.90 0.7758
2020-01-08 2019-12-31 13F AMGEN COM 031162100 4,956 0 0.00 1,195 24.61 0.7516
2019-10-08 2019-09-30 13F AMGEN COM 031162100 4,956 0 0.00 959 5.04 0.6497
2019-07-09 2019-06-30 13F AMGEN COM 031162100 4,956 -200 -3.88 913 -6.84 0.6259
2019-04-11 2019-03-31 13F AMGEN COM 031162100 5,156 -11 -0.21 980 -2.58 0.6832
2019-01-10 2018-12-31 13F AMGEN COM 031162100 5,167 0 0.00 1,006 -6.07 0.8071
2018-10-09 2018-09-30 13F AMGEN COM 031162100 5,167 11 0.21 1,071 12.50 0.7211
2018-07-13 2018-06-30 13F AMGEN COM 031162100 5,156 0 0.00 952 8.30 0.6715
2018-04-16 2018-03-31 13F AMGEN COM 031162100 5,156 -54 -1.04 879 -2.98 0.6291
2018-01-12 2017-12-31 13F AMGEN COM 031162100 5,210 54 1.05 906 -5.72 0.6260
2017-10-12 2017-09-30 13F AMGEN COM 031162100 5,156 0 0.00 961 8.22 0.7078
2017-07-20 2017-06-30 13F AMGEN COM 031162100 5,156 2,848 123.40 888 134.30 0.6741
2017-04-11 2017-03-31 13F AMGEN COM 031162100 2,308 -110 -4.55 379 7.06 0.2967
2017-01-19 2016-12-31 13F AMGEN COM 031162100 2,418 323 15.42 354 1.43 0.2866
2016-10-18 2016-09-30 13F AMGEN COM 031162100 2,095 -150 -6.68 349 2.05 0.3056
2016-07-15 2016-06-30 13F AMGEN COM 031162100 2,245 0 0.00 342 1.48 0.3094
2016-04-20 2016-03-31 13F AMGEN COM 031162100 2,245 -700 -23.77 337 -29.50 0.3256
2016-01-27 2015-12-31 13F AMGEN COM 031162100 2,945 0 0.00 478 17.44 0.4751
2015-10-19 2015-09-30 13F AMGEN COM 031162100 2,945 0 0.00 407 -9.96 0.4201
2015-07-20 2015-06-30 13F AMGEN COM 031162100 2,945 200 7.29 452 2.96 0.4162
2015-04-21 2015-03-31 13F AMGEN COM 031162100 2,745 2,745 439 0.4002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.